These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 386519)

  • 21. Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
    Weiss HJ
    Am Heart J; 1976 Jul; 92(1):86-102. PubMed ID: 785989
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.
    Vargaftig BB; Zirinis P
    Nat New Biol; 1973 Jul; 244(134):114-6. PubMed ID: 4517254
    [No Abstract]   [Full Text] [Related]  

  • 23. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
    Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
    Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiating effect of adenosine on other inhibitors of platelet aggregation.
    Murakami M; Odake K; Takase M; Yoshino K
    Thromb Diath Haemorrh; 1972 Apr; 27(2):252-62. PubMed ID: 5049615
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
    Rosenberg JC; Sell T
    Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
    [No Abstract]   [Full Text] [Related]  

  • 26. The measurement of intravascular aggregation by continuous platelet counting.
    Smith GM; Freuler F
    Bibl Anat; 1973; 12():229-34. PubMed ID: 4790356
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacology of platelet inhibition.
    Weiss HJ
    Prog Hemost Thromb; 1972; 1():199-231. PubMed ID: 4143961
    [No Abstract]   [Full Text] [Related]  

  • 28. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of aggregation inducers and inhibitors on the functional properties and the ultrastructure of platelets].
    Lakin KM; Makarow WA; Mular AG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):849-52. PubMed ID: 94877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination.
    Escolar G; Bastida E; Ordinas A; Castillo R
    Thromb Res; 1985 Nov; 40(3):419-24. PubMed ID: 4082117
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of antiadhesive drugs on platelet function and metabolism.
    Ulutin SB; Yaramanci TE; Ulutin ON
    Acta Univ Carol Med Monogr; 1972; 53():237-46. PubMed ID: 4670732
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibition of platelet aggregation: experimental findings and clinical prospects].
    de Gaetano G; Vermylen J; Verstraete M
    Nouv Rev Fr Hematol; 1971; 11(3):339-63. PubMed ID: 4256693
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
    [No Abstract]   [Full Text] [Related]  

  • 36. The action of halofenate on platelet shape change and prostaglandin synthesis.
    Favis GR; Colman RW
    J Lab Clin Med; 1978 Jul; 92(1):45-52. PubMed ID: 659964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ingestion of dipyridamole reduces inhibitory effect of prostacyclin on human platelets.
    Di Minno G; Silver MJ; De Gaetano G
    Lancet; 1979 Sep; 2(8144):701-2. PubMed ID: 90798
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of antiplatelet drugs on platelet function tests.
    Sirridge MS; Shannon R; Willoughby TL; Steele P
    Mo Med; 1979 Apr; 76(4):212-7. PubMed ID: 431521
    [No Abstract]   [Full Text] [Related]  

  • 39. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance.
    Willis AL; Vane FM; Kuhn DC; Scott CG; Petrin M
    Prostaglandins; 1974 Dec; 8(6):453-507. PubMed ID: 4471695
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet function studies in coronary artery disease. X. Effect of dipyridamole.
    Mehta J; Mehta P; Pepine CJ; Conti CR
    Am J Cardiol; 1981 May; 47(5):1111-4. PubMed ID: 7013461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.